• wonderlic tests
  • EXAM REVIEW
  • NCCCO Examination
  • Summary
  • Class notes
  • QUESTIONS & ANSWERS
  • NCLEX EXAM
  • Exam (elaborations)
  • Study guide
  • Latest nclex materials
  • HESI EXAMS
  • EXAMS AND CERTIFICATIONS
  • HESI ENTRANCE EXAM
  • ATI EXAM
  • NR AND NUR Exams
  • Gizmos
  • PORTAGE LEARNING
  • Ihuman Case Study
  • LETRS
  • NURS EXAM
  • NSG Exam
  • Testbanks
  • Vsim
  • Latest WGU
  • AQA PAPERS AND MARK SCHEME
  • DMV
  • WGU EXAM
  • exam bundles
  • Study Material
  • Study Notes
  • Test Prep

Course: Advanced Pharmacology

Exam (elaborations) Dec 16, 2025 ★★★★★ (5.0/5)
Loading...

Loading document viewer...

Page 0 of 0

Document Text

Chamberlain University

NR 546 / NR546

Week 3 Antipsychotics Table

Course: Advanced Pharmacology

  • / 2

Drug name Indica�on

Target symptoms: state if posi�ve or nega�ve

e�ect Potency (if noted. receptor occupancy if noted ) Neurotransmi�er(s) a�ected Half-life (T1/2), metabolism (CYP 450 enzyme) Notable side e�ects (associate to pathway or NT) Typical an�psycho�cs (conven�onal)

Haloperidol Target Symptoms:

Bipolar Disorder Psycho�c disorders Behavioral disturbances in demen�as Delirium w/ Lorazepam Schizophrenia Tics and vocal u�erances in Toure�es Syndrome Second line treatment of severe behavior in children of comba�ve explosive hyperexcitability

Potency:

High potency �rst-genera�on

Neurotransmi�ers:

Blocks dopamine 2 receptors, reducing posi�ve symptoms of psychosis and possibly comba�ve, explosive, and hyperac�ve behaviors Blocks dopamine 2 receptors in the nigrostriatal pathway, improving �cs and other symptoms in Toure�e’s syndrome.

Half-Life:

Decanoate is approx.

  • weeks

Oral: 12-38 hours

Metabolism:

CYP1A2

CYP2D6

CYP3A4

Notable Side E�ects:

Neurolep�c-induced de�cit syndrome Akathisia Drug-induced Parkinsonism Tardive dyskinesia, Tardive dystonia Risk of poten�ally irreversible involuntary dyskine�c movements may increase with cumula�ve dose and treatment dura�on Galactorrhea, Amenorrhea Dizziness Seda�on Dry mouth, cons�pa�on, urinary reten�on, blurred vision Decreased swea�ng Hypotension Tachycardia Hypertension Weight gain

Thioridazine Target Symptoms:

Schizophrenia

Potency:

Low-potency �rst-genera�on

Neurotransmi�ers:

Blocks dopamine 2 receptors, reducing posi�ve symptoms of psychosis

Half-Life:

21-24 Hours

Metabolism:

CYP450 2D6

Notable Side E�ects:

Neurolep�c-induced de�cit syndrome Akathisia Priapism Drug- induced parkinsonism Tardive dyskinesia Risk of poten�ally irreversible involuntary dyskine�c movements may increase with cumula�ve dose Downloaded by Benjamin Luca ([email protected]) lOMoARcPSD|51648332

  • / 2

User Reviews

★★★★★ (5.0/5 based on 1 reviews)
Login to Review
S
Student
May 21, 2025
★★★★★

I was amazed by the comprehensive coverage in this document. It was a perfect resource for my project. Truly excellent!

Download Document

Buy This Document

$1.00 One-time purchase
Buy Now
  • Full access to this document
  • Download anytime
  • No expiration

Document Information

Category: Exam (elaborations)
Added: Dec 16, 2025
Description:

Chamberlain University NR 546 / NR546 Week 3 Antipsychotics Table Course: Advanced Pharmacology Drug name Indica�on Target symptoms: state if posi�ve or nega�ve e򣌽...

Unlock Now
$ 1.00